Sarita Jairath
About Sarita Jairath
Executive Vice President and Global Head of Client Solutions at P10 (PX), age 44, appointed in September 2024, responsible for strategy and execution of organic growth via deepening investor relationships, product development, and platform positioning. Previously Managing Director at Blackstone’s Real Estate Institutional Client Solutions (BREDS) and leadership roles at Seix Investment Advisors, J.P. Morgan Private Bank, and Goldman Sachs; BBA (Emory) and MBA (Columbia) . Under her remit, PX emphasized scaling distribution, cross-platform collaboration, and product innovation (e.g., Enhanced Capital Evergreen Fund), supported by a 4,900+ investor base with strong wealth/HNW presence .
Company performance context during her tenure:
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|
| Revenue ($USD) | $84.0M* | $66.7M | $71.5M | $74.3M |
| EBITDA ($USD) | $52.8M* | $24.8M* | $19.4M* | $24.0M* |
Values retrieved from S&P Global.
Notes: PX reported fee-paying AUM growth and fundraising momentum consistent with this trajectory in 2025 earnings materials .
Past Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Blackstone (BREDS) | Managing Director, Real Estate Institutional Client Solutions; Global Co-Head, Diverse Professionals Network; DEI Executive Committee | 2019–2024 | Led capital raising/investor relations for debt strategies; broadened institutional relationships; diversity leadership aligning talent strategy with fundraising goals . |
| Seix Investment Advisors | Managing Director, Leveraged Finance IR/Marketing | Not disclosed | Built LP engagement and marketing for leveraged finance platform . |
| J.P. Morgan Private Bank | Executive Director, Credit Manager Research | Not disclosed | Oversaw research of credit managers, informing allocation decisions . |
| Goldman Sachs (IMD Capital Markets) | Vice President | Not disclosed | Capital markets execution supporting institutional client activities . |
External Roles
| Organization | Role | Years | Strategic Impact |
|---|---|---|---|
| Hospital for Special Surgery (HSS) | Pediatric Council member | Not disclosed | Governance/advisory engagement supporting pediatric initiatives . |
Fixed Compensation
- Not disclosed for non-NEO executive officers such as Ms. Jairath in PX’s 2025 proxy; Summary Compensation Table only covers CEO, CFO, and CAO .
Performance Compensation
- Not disclosed for Ms. Jairath. Company-level executive compensation components include cash bonus, RSUs, stock options, and carried interest (for certain executives), overseen by the Compensation Committee; clawback policy adopted in 2023 pursuant to SEC/NYSE rules .
- Equity grant policy: annual and mid-year grants possible; timing not tied to MNPI; most employee RSUs vest after one year, with different schedules for executive RSUs and program-specific awards .
Equity Ownership & Alignment
- Section 16 compliance: PX disclosed a late Form 4 filing by “Sarita Narson Jairath” on September 26, 2024 to report the grant of RSUs (details not provided in proxy) .
- Hedging/pledging: PX insider trading policy prohibits short-term trading, short sales, hedging, margin trading/pledging, and derivatives trading by directors, officers, employees and related persons—reducing misalignment risks .
- Vested vs unvested breakdown and ownership %: not disclosed for Ms. Jairath in the 2025 proxy; beneficial ownership table lists directors/NEOs and groups but does not itemize her holdings .
Employment Terms
- Appointment: EVP & Global Head of Client Solutions since September 2024 .
- Responsibilities: grow distribution, strategic partnerships across global pools of capital, leverage proprietary data/analytics to deepen cross-platform investor relationships, expand product offerings (including evergreen structures) .
- Contract terms (severance, change-of-control): not disclosed for Ms. Jairath; general executive policies include company-level clawback; CEO/CFO/CAO severance terms are detailed but not applicable/available for Ms. Jairath .
Performance & Track Record
- Distribution build-out: Drove structure/process for capital formation across client segments, leveraging ~4,900 LP relationships; increased cross-strategy adoption among existing LPs and cultivation of larger global pools of capital (insurance, pensions, endowments, foundations, sovereigns) .
- Product innovation: Led/endorsed launch of Enhanced Capital Evergreen Fund aimed at credit investors in open-ended format; focus on partnering through RIA platforms and institutional anchors rather than retail distribution build-out .
- Platform integration and data: Reconciled/optimized CRM and investor data across strategies to enable deeper engagement and cross-selling; management highlighted her execution and impact within first year .
Compensation Committee Analysis
- Composition (2025): Chair Tracey Benford; members Travis Barnes, Stephen Blewitt, and Robert Stewart Jr.; independent oversight and annual review of CEO/exec compensation, incentives, and equity plan administration .
- Equity grant practices: annual and mid-year grants possible; committee does not time grants to MNPI .
Risk Indicators & Red Flags
- Late Form 4 (Sept 26, 2024) noted for RSU grant reporting—procedural timeliness issue, but PX disclosed multiple late filings across various insiders in 2024; no allegation of misconduct .
- Hedging/pledging expressly prohibited, mitigating alignment concerns .
- No disclosed investigations, legal proceedings, or related-party concerns tied to Ms. Jairath in the 2025 proxy; PX related-party transactions primarily involve strategy-level agreements unrelated to Ms. Jairath .
Investment Implications
- Alignment: RSU grants and prohibition on hedging/pledging indicate positive alignment; lack of publicly disclosed ownership detail limits precision of “skin-in-the-game” analysis .
- Execution: Her early tenure shows tangible distribution/process improvements, cross-platform fundraising momentum, and product expansion (evergreen)—supports sustained fee-paying AUM growth and revenue durability in PX’s middle/lower-middle market focus .
- Retention risk: No employment/severance specifics disclosed for Ms. Jairath; continued progress in client solutions and product innovation suggests high strategic importance; monitor future proxies and any 8-K Item 5.02 filings for compensation and contract visibility .
- Trading signals: Company-level fundraising/FPAUM growth plus recurring fee model support earnings stability; for executive-specific signals, watch Form 4 activity and future RSU/option grants for vesting cliffs that could create selling pressure around anniversaries (most employee RSUs vest after one year; options often 5-year graded) .
S&P Global disclaimer applies to the quantitative table above.